» Articles » PMID: 31398812

Chlorin, Phthalocyanine, and Porphyrin Types Derivatives in Phototreatment of Cutaneous Manifestations: A Review

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2019 Aug 11
PMID 31398812
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Recent scientific research has shown the use of chlorin, phthalocyanines, and porphyrins derivatives as photosensitizers in photodynamic therapy in the treatment of various pathologies, including some of the major skin diseases. Thus, the main goal of this critical review is to catalog the papers that used these photosensitizers in the treatment of acne vulgaris, psoriasis, papillomavirus infections, cutaneous leishmaniasis, and skin rejuvenation, and to explore the photodynamic therapy mechanisms against these conditions alongside their clinical benefits.

Citing Articles

Photodynamic Therapy against Colorectal Cancer Using Porphin-Loaded Arene Ruthenium Cages.

Ghaddar S, Pinon A, Gallardo-Villagran M, Massoud J, Ouk C, Carrion C Int J Mol Sci. 2024; 25(19).

PMID: 39409175 PMC: 11476664. DOI: 10.3390/ijms251910847.


Porphyrin Photosensitizers into Polysaccharide-Based Biopolymer Hydrogels for Topical Photodynamic Therapy: Physicochemical and Pharmacotechnical Assessments.

Burloiu A, Ozon E, Musuc A, Anastasescu M, Socoteanu R, Atkinson I Gels. 2024; 10(8).

PMID: 39195028 PMC: 11353948. DOI: 10.3390/gels10080499.


In Silico and In Vitro Studies on an Asymmetrical Porphyrin Derivative with Therapeutic Potential in Skin Disorders.

Burloiu A, Mihai D, Manda G, Lupuliasa D, Neagoe I, Socoteanu R Pharmaceuticals (Basel). 2024; 17(6).

PMID: 38931355 PMC: 11206637. DOI: 10.3390/ph17060688.


A Novel Boron Dipyrromethene-Erlotinib Conjugate for Precise Photodynamic Therapy against Liver Cancer.

Wu W, Luo C, Zhu C, Cai Z, Liu J Int J Mol Sci. 2024; 25(12).

PMID: 38928126 PMC: 11203698. DOI: 10.3390/ijms25126421.


Assessment of Some Unsymmetrical Porphyrins as Promising Molecules for Photodynamic Therapy of Cutaneous Disorders.

Burloiu A, Manda G, Lupuliasa D, Socoteanu R, Mihai D, Neagoe I Pharmaceuticals (Basel). 2024; 17(1).

PMID: 38256895 PMC: 10818616. DOI: 10.3390/ph17010062.


References
1.
Sah J, Ito H, Kolli B, Peterson D, Sassa S, Chang K . Genetic rescue of Leishmania deficiency in porphyrin biosynthesis creates mutants suitable for analysis of cellular events in uroporphyria and for photodynamic therapy. J Biol Chem. 2002; 277(17):14902-9. DOI: 10.1074/jbc.M200107200. View

2.
Bissonnette R, Tremblay J, Juzenas P, Boushira M, Lui H . Systemic photodynamic therapy with aminolevulinic acid induces apoptosis in lesional T lymphocytes of psoriatic plaques. J Invest Dermatol. 2002; 119(1):77-83. DOI: 10.1046/j.1523-1747.2002.01827.x. View

3.
Gollnick H, Krautheim A . Topical treatment in acne: current status and future aspects. Dermatology. 2003; 206(1):29-36. DOI: 10.1159/000067820. View

4.
Zouboulis C, Piquero-Martin J . Update and future of systemic acne treatment. Dermatology. 2003; 206(1):37-53. DOI: 10.1159/000067821. View

5.
Alberola J, Rodriguez A, Francino O, Roura X, Rivas L, Andreu D . Safety and efficacy of antimicrobial peptides against naturally acquired leishmaniasis. Antimicrob Agents Chemother. 2004; 48(2):641-3. PMC: 321547. DOI: 10.1128/AAC.48.2.641-643.2004. View